Zusammenfassung
Im Zuge der Übertragung von Blut und Blutprodukten kam es in den vergangenen Jahren immer wieder zur Entwicklung von Hepatitiden, die serologisch nicht als Hepatitis A, B oder D identifiziert werden konnten. Im Zusammenhang mit diesen als Non-A-Non-B bezeichneten Hepatitiden konnte ein Virus gefunden werden, das nach Entwicklung eines spezifischen Antikörpertests zu dieser Erkrankung eine hohe Korrelation zeigte. Dieser, als Hepatitis-C-Virus benannte Erreger, scheint für einen Großteil der Non-A-Non-B-Hepatitiden verantwortlich zu sein [1, 3, 11].
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Literatur
Aneloni V, Vicarioto M, Doris R, Chiramonte M, Ongaro G, Naccarato R (1989) Relationship between Surrogate Tests for Prevention of NANB Post-Transfusion Hepatitis and Anti-HCV. 1st International Meeting on Hepatitis C Virus. Rome — September 14 and 15, 1989
Esteran JI, Viladomiu L, Gonzales A, Roget A, Genesea J, Esteban B, Lopez-Talavera JC, Hernandez JM, Vargas V, Buti M (1989) Hepatitis C Virus Antibodies among Risk Groups in Spain. Lancet 294–296
Kühnl P, Sibrowski W, Laufs R, Stangel W, Müller R, Seidl S (1989) HCV-Antibodies in NANBH-Patients and HIV Risk Groups. 1st International Meeting on Hepatitis C Virus. Rome — September 14 and 15, 1989
Maisonneuve P, Guerois C, Noel C, Verroust F, Laurian Y (1989) Anti-HCV Antibodies in French Hemophiliac only Substituted with Factor-VIII SD Concentrates. 1st International Meeting on Hepatitis C Virus. Rome — September 14 and 15, 1989
Mannucci PM, Schimpf K, Brettler DB, Colombo M, Lechner K, Lusher J, Roberts H (1989) Hepatitis C Virus is not Transmitted by High-Purity, Pasteurized Factor VIII Concentrate. 1st International Meeting on Hepatitis C Virus. Rome — September 14 and 15, 1989
Noel L, Verroust F, Maisoneuve P, Geurois C, Laurian Y (1989) Antibodies to Hepatitis C Virus in 400 French Patients with Hemophilia. 1st International Meeting on Hepatitis C Virus. Rome — September 14 and 15, 1989
Rommel F, Schramm W, Roggendorf M, Kammerer R, Pohlmann H, Rabhofer R, Gürtler L, Deinhardt F (1989) Prevelance of Antibodies to Hepatitis C Virus (HCV) in Hemophiliacs. 1st International Meeting on Hepatitis C Virus. Rome — September 14 and 15, 1989
Rumi MG, Colombo M. Gringeri A, Tradati FC, Mannucci PM (1989) High Prevalence of Antibody to Hepatitis C Virus in Multitransfused Hemophiliacs with Normal Aminotransferases. 1st International Meeting on Hepatitis C Virus. Rome — September 14 and 15, 1989
Schramm W, Roggendorf M, Rommel F, Kammerer R, Pohlmann R, Raßhofer R, Gürtler L, Deinhardt F (1989) Prevalence of Antibodies to Hepatitis C Virus (HCV) in Haemophiliacs. Blut 59:390–392
Skidmore J, Pasi KJ, Mawson SJ, Williams MD, Hill FGH (1989) Use of Anti-HCV Assay in Assessing the Safety of Clotting Factor Concentrates. 1st International Meeting on Hepatitis C Virus. Rome — September 14 and 15, 1989
Van der Poel, Lelie PN, Choo Q-L, Reesink HW, Leentvaar-Kuypers A, Kuo G (1989) Anti-Hepatitis C Antibodies and Non-A-Non-B Post-Transfusion Hepatitis in the Netherlands. Lancet 297–298
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1990 Springer-Verlag Berlin Heidelberg
About this paper
Cite this paper
Mondorf, W., Kühnl, P., Seidl, S., Aygören, E., Störkel, F., Scharrer, I. (1990). Vorläufige Ergebnisse der Anti-HCV-Testung von Patienten mit Blutgerinnungsstörungen. In: Landbeck, G., Marx, R., Scharrer, I., Schramm, W. (eds) 20. Hämophilie-Symposion Hamburg 1989. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-75923-9_19
Download citation
DOI: https://doi.org/10.1007/978-3-642-75923-9_19
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-540-52929-3
Online ISBN: 978-3-642-75923-9
eBook Packages: Springer Book Archive